Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases.

Lung cancer (Amsterdam, Netherlands) - 1 Nov 2014

Tseng Shih-En, Chiou Yi-You, Lee Yu-Chin, Perng Reury-Perng, Jacqueline Whang-Peng, Chen Yuh-Min

Abstract excerpt

BACKGROUND: In patients with non-small cell lung cancer (NSCLC), the development of liver metastasis (LM) is a poor prognostic factor. Whether systemic treatment combined with local treatment for LM has benefit for NSCLC patients with LM is unknown. METHODS: We retrospectively reviewed and analyzed the clinical data and tumor epidermal growth factor receptor (EGFR) mutation status of 673 pulmonary adenocarcinoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Adenocarcinoma of Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Combined Modality Therapy

Share to ErbB Receptors

Share to Liver Neoplasms

Share to Lung Neoplasms

Share to Treatment Outcome

Share to Tumor Burden

Source

Identifiers

PMID: 25240517
DOI: 10.1016/j.lungcan.2014.09.002

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Number of liver metastatic nodules affects treatment options for pulmonary adenocarcinoma patients with liver metastases.PMID 25240517Read ↗

The impact of de novo liver metastasis on clinical outcome in patients with advanced non-small-cell lung cancer.Semantic proximity Read ↗

Clinical characteristics of miliary pulmonary metastases in non-small cell lung cancer.Semantic proximity Read ↗

Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.Semantic proximity Read ↗

Characterization of Liver Metastasis and Its Effect on Targeted Therapy in EGFR-mutant NSCLC: A Multicenter Study.Semantic proximity Read ↗

The efficacy and safety of radiofrequency ablation in the treatment of inoperable patients with pulmonary malignant nodulesSemantic proximity Read ↗

Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis.Semantic proximity Read ↗

Innovation and Future Perspectives in the Treatment of Colorectal Liver Metastases.Semantic proximity Read ↗

Hepatic Metastases is Associated with Poor Efficacy of Erlotinib as 2nd/3rd Line Therapy in Patients with Lung Adenocarcinoma.Semantic proximity Read ↗

Hepatic metastasis is a poor predictive marker for erlotinib in lung adenocarcinoma.Semantic proximity Read ↗

Resection of adrenocortical carcinoma liver metastasis: is it justified?Semantic proximity Read ↗

EGFR‐TKIs plus local therapy demonstrated survival benefit than EGFR‐TKIs alone in EGFR‐mutant NSCLC patients with oligometastatic or oligoprogressive liver metastasesSemantic proximity Read ↗

Synchronous two-nodule hepatocellular carcinoma without satellite nodules is associated with better survival outcomes compared with satellite-nodule hepatocellular carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.